SCOPE 2019

Oracle integrates Quorum IRB tech to smooth submission process

By Melissa Fassbender

- Last updated on GMT

(Image: Getty/shirnosov)
(Image: Getty/shirnosov)

Related tags: Irb, Oracle, goBalto, regulatory approval, Clinical trials, Clinical development, Clinical operations

The collaboration between Quorum Review IRB and Oracle goBalto removes the need to send IRB submission documents manually.

The collaboration enables Quorum to push approval documents into Oracle goBalto’s Activate, explained Scott Smith, director of marketing at Quorum Review IRB. 

goBalto’s flagship product, Activate, is a study startup document and activity workflow solution that helps sponsors and contract research organizations (CROs) eliminate what it calls the three evil “e’s”: email, Excel, and e-rooms, according to the company, which was acquired by Oracle last year​.

Through the new collaboration, study teams will benefit from “point-and-click package submission and seamless data transfers,” ​Smith told us.

The integration also will use alerts to prevent errors and premature submissions. “Without this benefit, errors and submissions omissions become a time waster,”​ added Smith.

Oracle Health Sciences General Manager Steve Rosenberg said in a statement, “Automation has become critical for reducing the costs and complexities of clinical trials and this new level of integration eliminates time-consuming processes and improves operational efficiencies by addressing an entrenched bottleneck in the initiation process.”

Related news

Show more

Related products

show more

Overcoming Challenges of Clinical Data Review

Overcoming Challenges of Clinical Data Review

PerkinElmer | 10-Jun-2021 | Technical / White Paper

Clinical data review is intrinsic to clinical development, assuring patient safety, determining drug efficacy, and assessing data quality. It involves...

How clinical trial software can optimize trials

How clinical trial software can optimize trials

Formedix | 09-Jun-2021 | Technical / White Paper

This article explains the different types of clinical trial software available, and how it can be used to optimize the end to end clinical trials design...

Transforming Clinical Development

Transforming Clinical Development

PerkinElmer | 01-Jun-2021 | Technical / White Paper

The estimated cost of bringing a drug to market in the U.S. according to JAMA is $1 billion.1 The extreme cost of clinical trials urge biopharmaceutical,...

Related suppliers

Follow us

Products

View more

Webinars